During the past decade, University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology" #1 collaborator was "Autoimmunity Centers of Excellence" with 1 trials as a collaborator, "Corbus Pharmaceuticals Inc." with 1 trials as a collaborator and "Rho Federal Systems Division, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology" are "Lupus" (1 trials), "Lupus Nephritis" (1 trials), "SLE" (1 trials) and "Systemic Lupus Erythematosus" (1 trials). Many other conditions were trialed in "University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology" in a lesser frequency.

Most popular intervention types in "University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "JBT-101" (1 trials), "Placebo" (1 trials), "Placebo for VIB4920" (1 trials) and "VIB4920" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".